4.7 Article

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers

Shmuel Benenson et al.

Summary: A systematic vaccination program for healthcare workers at Hadassah Medical Center in Israel showed high effectiveness in preventing Covid-19 starting from the second week after the first dose of BNT162b2 vaccine.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California

Jocelyn Keehner et al.

Summary: A study showed that while 71% of healthcare workers tested positive for SARS-CoV-2 within 2 weeks after receiving the vaccine, the percentage decreased after the second dose.

NEW ENGLAND JOURNAL OF MEDICINE (2021)